Cargando…
CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
BACKGROUND: Defining endpoints for trachoma programs can be a challenge as clinical signs of infection may persist in the absence of detectable bacteria. Antibody-based tests may provide an alternative testing strategy for surveillance during terminal phases of the program. Antibody-based assays, in...
Autores principales: | Goodhew, E. Brook, Priest, Jeffrey W., Moss, Delynn M., Zhong, Guangming, Munoz, Beatriz, Mkocha, Harran, Martin, Diana L., West, Sheila K., Gaydos, Charlotte, Lammie, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486877/ https://www.ncbi.nlm.nih.gov/pubmed/23133684 http://dx.doi.org/10.1371/journal.pntd.0001873 |
Ejemplares similares
-
Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018) -
Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015) -
The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020) -
Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022) -
Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
por: Goodhew, Erica Brook, et al.
Publicado: (2014)